FOLH1 and breast carcinoma: Additionally, Yuri Tolkach et al. provided clinical evidence for PSMA-targeted RLT in breast cancer reporting on a TNBC patient treated with [177Lu]Lu-PSMA-RLT following significant tracer uptake on imaging.